TrialBMC medicine2025

Zanubrutinib, lenalidomide and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in non-germinal center B-cell diffuse large B-cell lymphoma: a multi-center phase 2 study by Jiangsu Cooperative Lymphoma Group (JCLG).

Yi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.